Cannabis finance news

Bioxyne upgrades revenue forecast on back of record Q2

by Martin Lane January 24, 2025January 29, 2025

Bioxyne has upgraded its revenue forecast for FY25 from A$20 million to $25m on the back […]

Montu pays out $6.3m to minority shareholders as buy-back scheme concludes

by Steve Jones January 23, 2025January 23, 2025

Melodiol Global Health creditors vote to wind up company

by Steve Jones January 23, 2025January 23, 2025

Deal for OneLife Wonthaggi facility expected to be finalised next month

by Steve Jones January 23, 2025January 23, 2025

Directors ‘may have breached duties’, report alleges, as Melodiol Global Health heads for liquidation

by Steve Jones January 15, 2025January 16, 2025

Talks continue over OneLife future as report spells out firm’s travails

by Steve Jones January 15, 2025January 16, 2025

Company news: Argent BioPharma; Greenfern Industries

by Martin Lane January 13, 2025January 13, 2025

Althea says A$2m placement exempt from ASX ruling on equity securities

by Martin Lane January 7, 2025January 7, 2025

Health House

Little Green Pharma set to acquire Health House for A$1.25m

by Steve Jones December 20, 2024April 11, 2025

Phytoca poised to sell business after Chinese firm flags ‘$62m’ deal

by Steve Jones December 19, 2024December 21, 2024